ACCD Accolade, Inc. Year-over-year earnings per share growth for the last twelve months

Accolade, Inc. (ACCD) - corporate logo

The quarterly earnings per share growth rate demonstrates how Accolade (ACCD) AI questionnaires optimize initial intake. Multi-year agreements with US corporations guarantee stability, while the -441.40 indicator determines the metric's magnitude. Scaling efficiency is driven by cloud navigation and self-service algorithms, which allow the company to expand its client base without inflating call center headcount.

accolade.com (ACCD) Year-over-year earnings per share growth for the last twelve months: for the period 07/04/2022 - 04/19/2025

Comprehensive metric breakdowns and analytics for Accolade (ACCD)

- share price and expert price forecast:
Stock Price accolade.com|ACCD - Consensus Target
- market capitalization data:
Market Value Accolade Health|ACCD - Total Enterprise Value
- book capitalization data:
Net Assets per Single Share Accolade|ACCD - Company Book Value|Market Capitalization to Book Value Ratio accolade.com|ACCD - Company Total Assets
- company liabilities and liquidity data:
Total Debt to Capital Accolade|ACCD - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital accolade.com|ACCD - Company Cumulative Debt|Debts to Book Capitalization Accolade Health|ACCD - Company Long-Term Debts|Company Short-Term Debts Accolade|Quick Ratio accolade.com
- earnings and market multiples details:
ACCD - Net Income|Projected Future Earnings Accolade|ACCD - Price to Earnings Multiple|Projected Price to Earnings accolade.com|ACCD - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple Accolade Health|ACCD - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Accolade|ACCD - Earnings per share for the last twelve months|Quarterly EPS earnings growth accolade.com|ACCD - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Accolade
Comprehensive company analysis:Accolade Inc - ACCD
Flagship merchandise of Accolade

The selection of high-quality issuers is based on an analysis of profit scaling rates, where earnings per share dynamics serve as the key filter. This metric measures the quarterly change in net income, reflecting the efficiency of the Accolade (ACCD) IT platform in optimizing corporate healthcare expenditures, which allows investors to assess the actual financial result through the fact of quarterly EPS growth.

Competitor analysis

HIMS: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Hinge Health, Inc.|Year-over-year earnings per share growth for the last twelve months Teladoc Inc.|Earnings per share growth in annualized terms for the last twelve months Talkspace Platform TALK|Year-over-year earnings per share growth for the last twelve months LifeMD, Inc. (LFMD)|Year-over-year earnings per share growth for the last twelve months AMWL (amwell.com)|Quarterly EPS earnings growth MGRX (Mangoceuticals)|Quarterly EPS earnings growth DarioHealth Corp DRIO|VSee - Quarterly EPS earnings growth|MNDR (Mobile-health Corp) - Year-over-year earnings per share growth for the last 12 months|BTCY: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months lytuscorp.com (LYT)|OTRK (Ontrak) - Quarterly EPS earnings growth|Quarterly EPS earnings growth SHL Telemedicine, Ltd.|Quarterly EPS earnings growth THRN